Verapamil Toxicity in Hypertrophic Cardiomyopathy
Author Information
Author(s): Gau Jonathan W, Rader Florian, Mody Behram, Lee Andy Y
Primary Institution: University of California, Irvine
Hypothesis
Can verapamil toxicity lead to hemodynamic compromise in patients with obstructive hypertrophic cardiomyopathy?
Conclusion
Verapamil toxicity can cause significant hemodynamic issues in patients with obstructive hypertrophic cardiomyopathy.
Supporting Evidence
- The patient experienced cardiogenic shock attributed to verapamil toxicity.
- His ejection fraction improved from 35% to 75% after adjusting medications.
- Verapamil's negative inotropic effects were highlighted as a concern in this case.
Takeaway
This study shows that taking too much verapamil can make it hard for the heart to pump blood in people with a specific heart condition.
Methodology
Case report detailing a patient's experience with verapamil toxicity and its effects on heart function.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
A 34-year-old man with a history of obstructive hypertrophic cardiomyopathy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website